Lv11
34 积分 2024-09-18 加入
Urological diagnosis, history and investigation
31分钟前
已完结
Trend of drug clinical trials in mainland China from 2009 to 2020
1个月前
已完结
Fibroblast Activation Protein Inhibitor Theranostics
1个月前
已完结
Biparatopic anti-HER2 drug radioconjugates as breast cancer theranostics
2个月前
已完结
Is preoperative imaging of sentinel lymph node in breast cancer necessary? A retrospective case control study
2个月前
已完结
Development of multivalent FAP-targeted Small Molecule-Drug Conjugates with tailored MMAE release kinetics
3个月前
已完结
Safety of Fibroblast Activation Protein–Targeted Radionuclide Therapy by a Low-Dose Dosimetric Approach Using 177Lu-FAPI04
4个月前
已完结
Feasibility and Therapeutic Potential of 177Lu–Fibroblast Activation Protein Inhibitor–46 for Patients With Relapsed or Refractory Cancers
4个月前
已完结
[177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial
4个月前
已完结
[177Lu]Lu-FAPI Radioligand Therapy: Emerging Horizons and Clinical Promise in Solid Tumors: A Comprehensive Review
4个月前
已完结
皖公网安备34019202002308
